| Ellen Knipfer, MSN, RN, FNP-BC | |
|
815 Jefferson St, Algoma, WI 54201-1733 | |
| (920) 487-3496 | |
| Not Available |
| Full Name | Ellen Knipfer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 815 Jefferson St, Algoma, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144629114 | NPI | - | NPPES |
| 164467-30 | Other | WI | REGISTERED NURSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 5998-33 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension At Home | Sturgeon bay, WI | Home health agency |
| Door County Medical Center | Sturgeon bay, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Door County Memorial Hospital | 5395735088 | 66 |
News Archive
The Hispanic Health Disparities Research Center at the University of Texas at El Paso has received a $6.8 million grant from the National Institutes of Health that will significantly advance the center's research in helping eliminate racial and ethnic health inequalities across the nation.
Swedish researchers have found a link between eating processed meat, such as bacon or sausages, and pancreatic cancer. They said eating an extra 50g of processed meat, approximately one sausage, every day would increase a person's risk of getting pancreatic cancer by 19%. But the chance of developing the rare cancer remains low they added.
In a small clinical trial led by the Johns Hopkins Bloomberg School of Public Health, researchers say that a promising single-dose dengue vaccine, developed by scientists at the National Institutes of Health, was 100 percent effective in preventing human volunteers from contracting the virus, the most prevalent mosquito-borne virus in the world.
Biotechnology firm Viral Genetics, Inc. has been issued a patent for novel cancer therapies. The patent protects cancer drugs that have been tested in pre-clinical research studies in mice. Issued on March 31, 2009, the U.S. Patent Number is: 7,510,710. Additional patents directed at generic classes of the drugs are still pending.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
› Verified 3 days ago
| Entity Name | Door County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093743874 PECOS PAC ID: 5395735088 Enrollment ID: O20040514000588 |
News Archive
The Hispanic Health Disparities Research Center at the University of Texas at El Paso has received a $6.8 million grant from the National Institutes of Health that will significantly advance the center's research in helping eliminate racial and ethnic health inequalities across the nation.
Swedish researchers have found a link between eating processed meat, such as bacon or sausages, and pancreatic cancer. They said eating an extra 50g of processed meat, approximately one sausage, every day would increase a person's risk of getting pancreatic cancer by 19%. But the chance of developing the rare cancer remains low they added.
In a small clinical trial led by the Johns Hopkins Bloomberg School of Public Health, researchers say that a promising single-dose dengue vaccine, developed by scientists at the National Institutes of Health, was 100 percent effective in preventing human volunteers from contracting the virus, the most prevalent mosquito-borne virus in the world.
Biotechnology firm Viral Genetics, Inc. has been issued a patent for novel cancer therapies. The patent protects cancer drugs that have been tested in pre-clinical research studies in mice. Issued on March 31, 2009, the U.S. Patent Number is: 7,510,710. Additional patents directed at generic classes of the drugs are still pending.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ellen Knipfer, MSN, RN, FNP-BC 323 S 18th Ave, Sturgeon Bay, WI 54235-1401 Ph: (920) 746-0510 | Ellen Knipfer, MSN, RN, FNP-BC 815 Jefferson St, Algoma, WI 54201-1733 Ph: (920) 487-3496 |
News Archive
The Hispanic Health Disparities Research Center at the University of Texas at El Paso has received a $6.8 million grant from the National Institutes of Health that will significantly advance the center's research in helping eliminate racial and ethnic health inequalities across the nation.
Swedish researchers have found a link between eating processed meat, such as bacon or sausages, and pancreatic cancer. They said eating an extra 50g of processed meat, approximately one sausage, every day would increase a person's risk of getting pancreatic cancer by 19%. But the chance of developing the rare cancer remains low they added.
In a small clinical trial led by the Johns Hopkins Bloomberg School of Public Health, researchers say that a promising single-dose dengue vaccine, developed by scientists at the National Institutes of Health, was 100 percent effective in preventing human volunteers from contracting the virus, the most prevalent mosquito-borne virus in the world.
Biotechnology firm Viral Genetics, Inc. has been issued a patent for novel cancer therapies. The patent protects cancer drugs that have been tested in pre-clinical research studies in mice. Issued on March 31, 2009, the U.S. Patent Number is: 7,510,710. Additional patents directed at generic classes of the drugs are still pending.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
› Verified 3 days ago